Stability study of nanoparticles of poly(ε-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide)

Biomaterials

Volumn 17, Issue 22, 1996, Pages 2191-2197

  Lemoine, D ^a   Francois, C ^b   Kedzierewicz, F ^b   Preat, V ^a   Hoffman, M ^b   Maincent, P ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Nanoparticles; Poly(D,L lactide); Poly(D,L lactide co glycolide); Poly( caprolactone); Stability

Indexed keywords

CRYSTAL STRUCTURE; MOLECULAR WEIGHT; NANOSTRUCTURED MATERIALS; PARTICLE SIZE ANALYSIS; PH; STORAGE (MATERIALS); THERMAL EFFECTS;

NANOPARTICLES; POLYMER CRYSTALLINITY;

POLYESTERS;

BIOMATERIAL; NANOPARTICLE; POLYGLACTIN; POLYLACTIDE; POLYMER;

ARTICLE; MOLECULAR WEIGHT; POLYMERIZATION; PRIORITY JOURNAL; PROSTHESIS MATERIAL;

EID: 0030298086     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/0142-9612(96)00049-X     Document Type: Article

References (24)

1. 1 Mauduit J, Vert M. Les polymères à base d'acides lactiques et glycoliques et la délivrance contrôlée des principes actifs. STP Pharma Sciences 1993; 3: 197-212.
2. 2 Lewis DH. Controlled release of bioactive agents from lactide/glycolide polymers. In: Chasis M, Langer R, eds. Biodegradable Polymers as Drug Delivery Systems. New York: Marcel Dekker, 1991: 1-41.
3. 3 Holland SJ, Tighe BJ. Polymers for biodegradable medical devices. I. The potential of polyesters as controlled macromolecular release systems. J Contr Rel 1986; 4: 155-180.
4. 4 Wise DL, Fellmann TD, Sanderson JE, Wentworth RL. Lactic/glycolic acid polymers. In: Drug Carriers in Biology and Medicine. London. Academic Press, 1979: 236-270.
5. 5 Doelker E. Proposition de classification des polymères biocompatibles pour les formes médicamenteuses à libération contrôlée. STP Pharma 1987; 3: 207-215.
6. 6 Chawla AS, Chang TMS. In vivo degradation of poly(lactic acid) of different molecular weights. Biomater Med Dev Artif Organs 1985-1986; 13: 153-162.
7. 7 Li SM, Garreau H, Vert M. Structure-property relationships in the case of the degradation of massive poly(alpha-hydroxy acids) in aqueous media. III. Influence of the morphology of poly(L-lactic acid). J Mater Sci Mater Med 1990; 1: 198-206.
8. 8 Kaetsu I, Yoshida M, Asano M et al. Biodegradable implant composites for local therapy. J Contr Rel 1987; 6: 249-263.
9. 9 Reed AM, Gilding DK. Biodegradable polymers for use in surgery. Poly(glycolic acid)/poly(lactic acid) homo and copolymers. II. In vitro degradation. Polymer 1981; 22: 494-498.
10. 10 Makino K, Ohshima H, Kondo T. Mechanism of hydrolytic degradation of poly(L-lactide) microcapsules: effect of pH, ionic strength and buffer concentration. J Microencapsulation 1986; 3: 203-212.
11. 11 Nair PD, Sreenivasan K, Jayabalan M. Multiple gamma radiation sterilization of polyester fibres. Biomaterials 1988; 9: 335-338.
12. 12 Vert M, Li SM, Garreau H. Attempts to map the structure and degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids. J Biomater Sci Polym Ed 1994; 6: 639-649.
13. 13 Vert M, Mauduit J, Li SM. Biodegradation of PLA/GA polymers: increasing complexity. Biomaterials 1994; 15: 1209-1213.
14. 14 Li S, Vert M. Morphological changes resulting from the hydrolytic degradation of stereocopolymers derived from L-and DL-lactides. Macromolecules 1994; 27: 3107-3110.
15. 15 Cha Y, Pitt CG. The biodegradability of polyester blends. Biomaterials 1990; 11: 108-112.
16. 16 Sawhney AS, Hubbell JA. Rapidly degraded terpolymers of D,L-lactide, glycolide and ε-caprolactone with increased hydrophobicity by copolymerization with polyesters. J Biomed Mater Res 1990; 24: 1397-1411.
17. 17 Zhang X, Wyss UP, Pichora D, Goossen MFA. An investigation of poly(lactic acid) degradation. J Biomed Mater Res 1994; 9: 80-100.
18. 18 Vert M, Li S, Garreau H. More about the degradation of LA/GA-derived matrices in aqueous media. J Contr Rel 1991; 16: 15-26.
19. 19 Spenlehauer G, Vert M, Benoit JP, Boddaert A. In vitro and in vivo degradation of poly(D,L-lactide/glycolide) type microspheres made by solvent evaporation method. Biomaterials 1989; 10: 557-563.
20. 20 Park TG. Degradation of poly(D,L-lactic glycolic acid) microspheres: effect of molecular weight. J Contr Rel 1994; 30: 161-173.
21. 21 Makino K, Arakawa M, Kondo T. Preparation and in vitro degradation properties of polylactide microcapsules. Chem Pharm Bull 1985; 33: 1195-1201.
22. 22 Coffin MD, McGinity JW. Biodegradables pseudolatexes: the chemical stability of poly(D,L-lactide) and poly(D,L-lactide) and poly(ε-caprolactone) nanoparticles in aqueous media. Pharm Res 1992; 9: 200-205.
23. 23 Schmitt EA, Flanagan DR, Linhardt RJ. Degradation and release properties of pellets fabricated from three commercial poly(D,L-lactide-co-glycolide) biodegradable polymers. J Pharm Sci 1993; 82: 326-329.
24. 24 Fessi H, Puisieux F, Devissaguet JP, Ammoury N, Benita S. Nanocapsules deposition by interfacial polymer deposition following solvent deplacement. Int J Pharm 1989; 55: R1-R4.